Similar Articles
Redefining multiple sclerosis: 2024 McDonald diagnostic criteria
Hazal Ceren Manazoğlu, Murat Kürtüncü
DOI: 10.55697/tnd.2025.500
Issue: 2025, Volume 31 - Issue 3
15939
10133
Association of lifestyle, psychological, and biological risk factors with multiple sclerosis: A case-control study
Rahim Aliyev, Aytan Mammadbayli, Rana Shiraliyeva
DOI: 10.55697/tnd.2025.494
Issue: 2025, Volume 31 - Issue 3
1988
1360
Long-term cladribine experience in relapsing-remitting multiple sclerosis
Ömer Faruk Turan, Furkan Sarıdaş, Emine Rabia Koç
DOI: 10.55697/tnd.2025.293
Issue: 2025, Volume 31 - Issue 3
1433
1264
Association between urinary symptoms, quality of life, and pelvic floor function in females diagnosed with multiple sclerosis
Seda Kılıç, Ayşe Neriman Yılmaz, Murat Terzi
DOI: 10.55697/tnd.2025.323
Issue: 2025, Volume 31 - Issue 4
847
816
Audiovestibular findings according to the subtypes of multiple sclerosis
Fatmanur Uysal, Selim S. Erbek, Alper Köycü, Osman Halit Çam, Meliha Güleryüz
DOI: 10.55697/tnd.2025.442
Issue: 2025, Volume 31 - Issue 4
700
898
Development of restless legs syndrome severity prediction models for people with multiple sclerosis using machine learning
Ergi Kaya, Murat Emeç, Asiye Tuba Özdoğar, Ela Simay Zengin, Hilal Karakaş, Seda Daştan, Cavid Baba, Mehmet Hilal Özcanhan, Serkan Özakbaş
DOI: 10.55697/tnd.2025.511
Issue: 2025, Volume 31 - Issue 4
931
872
Nationwide prescription big data: An evaluation of injectable, oral, and monoclonal antibody disease-modifying therapies in multiple sclerosis
Esra Taşkıran, Bilgin Öztürk, Naim Ata, Şuayip Birinci
DOI: 10.55697/tnd.2026.622
Issue: 2026, Volume 32 - Issue 1
270
243